Changing patterns of human immunodeficiency virus-associated neuropathology

Annals of Indian Academy of Neurology

Volumn 10, Issue 2, 2007, Pages 69-80

  Gray, Francoise ^a   Scaravilli, Francesco ^b   Miller, Robert ^c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Acquired immunodeficiency syndrome; Highly active antiretroviral therapy; History of diseases; HIV dementia; Human immunodeficiency virus (HIV); Neuropathology; Pathogenesis

Indexed keywords

AMPRENAVIR; EFAVIRENZ; ENFUVIRTIDE; INTEGRASE INHIBITOR; LAMIVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; RALTEGRAVIR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; UNCLASSIFIED DRUG; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOPSY; BLOOD BRAIN BARRIER; BRAIN DISEASE; CLINICAL STUDY; COGNITIVE DEFECT; DEATH; DEMENTIA; DIAGNOSTIC ACCURACY; EXPERIMENTAL STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXPECTANCY; NEUROLOGICAL COMPLICATION; NEUROPATHOLOGY; PATHOGENESIS; PROGNOSIS; REVIEW;

EID: 34447132025     PISSN: 09722327     EISSN: None     Source Type: Journal    
DOI: 10.4103/0972-2327.33213     Document Type: Review

References (164)

1. Nathan DG. Clinical research: Perceptions, reality and proposed solutions. National Institute of Health Director's Panel on Clinical Research. JAMA 1998;280:1427-31.
2. Phoolcharoen W. HIV/AIDS prevention in Thailand: Success and challenges. Science 1998;280:1873-4.
3. Shacker T, Collier AC, Hughes J, Shea T, Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Int Med 1996;125:257-64.
4. Opportunistic infections and Kaposi's sarcoma among Haitians in the United States. Conn Med 1982;46:727-8.
5. Barré-Sinoussi F, Cherman JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome. Science 1983;220:868-71.
6. Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation and continuous production of cytopathic retrovirus (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984;224:497-500.
7. Snider WD, Simpson DM, Nielsen S, Gold JW, Metroka CE, Posner JB. Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients. Ann Neurol 1983;14:403-18.
8. Gray F, Geny C, Lionnet F, Dournon E, Fenelon G, Gherardi R, et al. Neuropathologic study of 135 adult cases of acquired immunodeficiency syndrome (AIDS) Ann Pathol 1991;11:236-47.
9. Sharer LR. Pathology of HIV-1 infection of the central nervous system. A review. J Neuropathol Exp Neurol 1992;51:3-11.
10. Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984;224:500-3.
11. nd ed, vol 2. Supplements and appendices. Cold Spring Harbor Laboratory: New York; 1985. p. 405-85.
12. Daniel MD, Letvin NL, King NW, Kannagi M, Sehgal PK, Hunt RD, et al. Isolation of t-cell tropic HTLV-III-like retrovirus from macaques. Science 1985;228:1201-4.
13. Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999;397:436-41.
14. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986a;19:525-35.
15. Witte MH, Witte CL, Minnich LL, Finley PR, Drake WL Jr. AIDS in 1968. JAMA 1984;251:2657.
16. Dalgliesh AG, Beverley PC, Clapman PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1985;312:767-7.
17. Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend D, et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984;312:767-8.
18. Meltzer MS, Gendelman HE. Mononuclear phagocytes as targets, tissue reservoirs and immunoregulatory cells in human immunodeficiency virus disease. Curr Top Microbiol Immunol 1992;181:239-63.
19. Vazeux R, Brousse N, Jarry A, Henin D, Marche C, Vedrenne C, et al. AIDS subacute encephalitis. Identification of HIV-infected cells. Am J Pathol 1987;126:403-10.
20. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: Functional cDNA cloning of a seven transmembrane, G protein-coupled receptor. Science 1996;272:872-7.
21. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
22. Evans LA, Levy JA. Characteristics of HIV infection and pathogenesis. Biochem Biophys Acta 1989;989:237-54.
23. Harcourt-Webster JN. General pathology. In: Scaravilli F, editor. The neuropathology of HIV infection. Springer: London; 1993. p. 53-98.
24. Lang W, Miklossy J, Deruaz JP, Pizzolato GP, Probst A, Schaffner T, et al. Neuropathology of the acquired immune deficiency syndrome (AIDS): A report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol 1989;77:379-90.
25. Morgello S, Cho ES, Nielsen S, Devinsky O, Petito CK. Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: An autopsy study of 30 cases and a review of the literature. Hum Pathol 1987;18:289-97.
26. Petito CK, Cho ES, Lemann W, Navia BA, Price RW. Neuropathology of acquired immunodeficiency syndrome (AIDS):an autopsy review. J Neuropathol Exp Neurol 1986;45:635-46.
27. Budka H, Costanzi G, Cristina S, Lechi A, Parravicini C, Trabattoni R, et al. Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol (Berl) 1987;75:186-98.
28. Vinters HV, Tomiyasu U, Anders KH. Neuropathologic complications of infection with the human immunodeficiency virus (HIV). Prog AIDS Pathol 1989;1:101-30.
29. Kovacs JA, Kovacs AA, Polis M, Wright WC, Gill VJ, Tuazon CU, et al. Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 1985;103:533-8.
30. Gray F, Gherardi R, Keohane C, Favolini M, Sobel A, Poirier J. Pathology of the central nervous system in 40 cases of acquired immune deficiency syndrome (AIDS). Neuropathol Appl Neurobiol 1988;14:365-80l.
31. Hénin D, Duyckaerts C, Chaunu MP, Vazeux R, Brousse N, Rozenbaum W, et al. Neuropathological study of 31 cases of acquired immunodeficiency syndrome. Rev Neurol (Paris) 1987;143:631-42.
32. Levy RM, Bredesen DE, Rosenblum ML. Opportunistic central nervous system pathology in patients with AIDS. Ann Neurol 1988;23:S7-12.
33. Luft BJ, Brooks RG, Conley FK, McCabe RE, Remington JS. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. JAMA 1984;252:913-7.
34. Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 1981;41:4253-61.
35. Fauci AS, Macher AM, Longo DL, Lane HC, Rook AH, Masur H, et al. Acquired immunodeficiency syndrome: Epidemiologic, clinical, immunologic and therapeutic considerations. Ann Int Med 1984;100:92-106.
36. Geddes JF, Battacharjee MB, Savage K, Scaravilli F, McLaughlin JE. Primary cerebral lymphoma: A study of 47 cases probed for Epstein-Barr virus genome. J Clin Pathol 1992;45:587-90.
37. Shaw GM, Harper ME, Hahn BH, Epstein LG, Gajdusek DC, Price RW, et al. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 1985;227:177-82.
38. Sharer LR, Cho ES, Epstein LG. Multinucleated giant cells and HTLV-III in AIDS encephalopathy. Hum Pathol 1985;16:760.
39. Budka H. Multinucleated giant cells in brain: A hallmark of the acquired immune deficiency syndrome (AIDS). Acta Neuropathol 1986;69:253-8.
40. Budka H, Wiley CA, Kleihues P, Artigas J, Asbury AK, Cho ES, et al. HIV associated disease of the nervous system: Review and nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1991;1:143-52.
41. Schmidbauer M, Huemer M, Cristina S. Morphological spectrum, distribution and clinical correlations of white matter lesions in AIDS brains. Neuropathol Appl Neurobiol 1982;18:489-501.
42. Smith TW, De Girolami U, Hénin D, Bolgert F, Hauw JJ. Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J Neuropathol Exp Neurol 1990;49:357-70.
43. Power C, Kong PA, Crawford TO, Wesselingh S, Glass JD, McArthur JC, et al. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood-brain-barrier. Ann Neurol 1993;34:339-50.
44. Boven LA, Middle J, Verhoef J, De Groot CJ, Nottet HS. Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV-a-associated dementia. Neuropathol Appl Neurobiol 2000;26:356-60.
45. Petito CK, Cask KS. Blood brain barrier abnormality in the acquired immunodeficiency syndrome: Immunohistochemical localization of serum proteins in post-mortem brain. Ann Neurol 1992;32:658-66.
46. Ciardi A, Sinclair E, Scaravilli F, Harcourt-Webster NJ, Lucas S. The involvement of the cerebral cortex in human immunodeficiency virus encephalopathy: A morphological and immunohistochemical study. Acta Neuropathol (Berl) 1990;81:51-9.
47. Everall IP, Luthert P, Lantos PL. A review of neuronal damage in human immunodeficiency virus infection: Its assessment, possible mechanism and relationship to dementia. J Neuropathol Exp Neurol 1993;52:561-6.
48. Adle-Biassette H, Levy Y, Colombel M, Poron F, Natchev S, Keohane C, et al. Neuronal apoptosis in HIV infection in adults. Neuopathol Appl Neurobiol 1995;21:218-27.
49. Petito CK, Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol 1995;146:1121-30.
50. Shi B, De Girolami U, He J, Wang S, Lorenzo A, Busciglio J, et al. Apoptosis induced by HIV-1 infection of the central nervous system. J Clin Invest 1996;98:1979-90.
51. Epstein LG, Sharer LR, Goudsmit J. Neurological and neuropathological features of human immunodeficiency virus infection in children. Ann Neurol 1988;23:S19-23.
52. Sharer LR, Cho ES. Neuropathology of HIV infection:adults vs children. Progr AIDS Pathol 1989;1:131-41.
53. Sharer LR, Epstein LG, Cho ES, Joshi VV, Meyenhofer MF, Rankin LF, et al. Pathologic features of AIDS encephalopathy in children: Evidence for LAV/HTLV-III infection of brain. Hum Pathol 1986;17:271-84.
54. Gelbard HA, James HJ, Sharer LR, Perry SW, Saito Y, Kazee AM, et al. Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol Appl Neurobiol 1995;21:208-17.
55. Esiri MM, Scaravilli F, Millard PR, Harcourt-Webster JN. Neuropathology of HIV infection in haemophiliacs: Comparative necropsy study. BMJ 1989;299:1312-5.
56. Bell JE, Brettle RP, Chiswick A, Simmonds P. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 1998;121:2043-52.
57. Goldstick L, Mandybur TI, Bode R. Spinal cord degeneration in AIDS. Neurology 1985;35:103-6.
58. Artigas J, Grosse G, Niedobitek F. Vacuolar myelopathy in AIDS. A morphological analysis. Pathol Res Pract 1990;186:228-37.
59. Sharer LR, Dowling PC, Michaels J, Cook SD, Menonna J, Blumberg BM, et al. Spinal cord disease in children with HIV-1 infection: A combined molecular biological and neuropathological study. Neuropathol Appl Neurobiol 1990;16:317-31.
60. Petito CK, Navia BA, Cho ES, Jordan BD, George DC, Price RW. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with acquired immunodeficiency syndrome. N Engl J Med 1985;312:874-9.
61. Tan SV, Guiloff RJ, Scaravilli F. AIDS-associated vacuolar myelopathy. A morphometric study. Brain 1995;118:1247-61.
62. Budka H, Maier H, Pokl P. Human immunodeficiency virus in vacuolar myelopathy of the acquired immunodeficiency syndrome. N Engl J Med 1988;319:1667-8.
63. Maier H, Budka H, Lassmann H, Pohl P. Vacuolar myelopathy with multinucleated giant cells in the acquired immunodeficiency syndrome (AIDS). Light and electron microscopic distribution of the human immunodeficiency virus (HIV) antigens. Acta Neuropathol 1989;78:497-503.
64. Kamin SS, Petito CK. Idiopathic myelopathies with white matter vacuolation in non-acquired immunodeficiency patients. Hum Pathol 1991;22:816-24.
65. Tyor WR, Glass JD, Baumrind N, McArthur JC, Griffin JW, Becker PS, et al. Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology 1993;43:1002-9.
66. Kimura-Kuroda J, Nagashima K, Yasui K. Inhibition of myelin formation by HIV-1 gp-120 in rat cerebral cortex culture. Arch Virol 1994;137:81-99.
67. Mizusawa H, Hirano A, Llena JF, Shintaku M. Cerebrovascular lesions in acquired immunodeficiency syndrome (AIDS). Acta Neuropathol 1988;76:451-7.
68. Yankner BA, Skolnik PR, Shoukimas GM, Gabuzda DH, Sobel RA, Ho DD. Cerebral granulomatous angiitis associated with isolation of human lymphotropic virus type III from the central nervous system. Ann Neurol 1986;20:362-4.
69. Scaravilli F, Daniel SE, Harcourt-Webster N, Guiloff RJ. Chronic basal meningitis and vasculitis in acquired immunodeficiency syndrome. A possible role for human immunodeficiency virus. Arch Pathol Lab Med 1989;113:192-5.
70. An SF, Groves M, Giometto B, Beckett AA, Scaravilli F. Detection and localisation of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction/in situ hybridisation technique. Acta Neuropathol 1999;98:481-7.
71. Saito Y, Sharer LR, Epstein LG, Michaels J, Mintz M, Louder M, et al. Over expression of nef as a marker for restricted HIV-1 infection of astrocytes in post-mortem pediatric central nervous tissue. Neurology 1994;44:474-81.
72. Tornatore C, Chandra R, Berger JR, Major EO. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 1994;44:481-7.
73. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB. Cellular localisation of human immunodeficiency virus infection within the brains of acquired immunodeficiency syndrome patients. Proc Natl Acad Sci USA 1986;83:7089-93.
74. Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Tawadros R, et al. Cell reservoirs of HIV-1 in the central nervous system of infected individuals: Identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 1996;10:573-5.
75. Sharer LR, Saito Y, Epstein LG, Blumberg BM. Detection of HIV-1 DNA in pediatric AIDS brain tissue by two step ISPCR. Adv Neuroimmunol 1994;4:283-5.
76. Bissel SJ, Wiley CA. Human immunodeficiency virus infection of the brain: Pitfalls in evaluating infected/affected cell populations. Brain Pathol 2004;14:97-108.
77. Nath A, Conant K, Chen P, Scott C, Major EO. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J Biol Chem 1999;274:17098-101.
78. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001;410:988-94.
79. Bruce-Keller AJ, Chauhan A, Dimayuga FO, Gee J, Keller JN, Nath A. Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicityand gliosis in rat brain. J Neurosci 2003;23:8417-22.
80. Dewhurst S, Gelbard HA, Fine SM. Neuropathogenesis of AIDS. Mol Med Today 1996;2:16-23.
81. Haughey NJ, Nath A, Mattson MP, Slevin JT, Geiger JD. HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J Neurochem 2001;78:457-67.
82. Lipton SA. HIV-related neurotoxicity. Brain Pathol 1991;1:193-9.
83. Ferrarese C, Aliprandi A, Tremolizzo L, Stanzani L, De Micheli A, Dolara A, et al. Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 2001;57:671-5.
84. Heyes MP, Ellis RJ, Ryan L, Childers ME, Grant I, Wolfson T, et al. Elevated cerebro spinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection. Brain 2001;124:1033-42.
85. Gras G, Chrétien F, Vallat-Decouvelaere AV, Le Pavec G, Porcheray F, Bossuet C, et al. Regulated expression of sodium-dependent glutamate transporters and synthetase: A neuroprotective role for activated microglia and macrophages in HIV infection? Brain Pathol 2003;13:211-22.
86. Vallat-Decouvelaere AV, Chrétien F, Gras G, Le Pavec G, Dormont D, Gray F. Expression of excitatory amino acidtransporter-1 in brain macrophages and microglia of HIV patients. A neuroprotective role for microglia? J Neuropathol Exp Neurol 2003;62:475-85.
87. Xu Y, Kulkosky J, Acheampong E, Nunnari G, Sullivan J, Pomerantz RJ. HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathy. Proc Natl Acad Sci USA 2004;101:7070-5.
88. Adle-Biassette H, Chrétien F, Wingertsmann L, Hery C, Ereau T, Scaravilli F, et al. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 1999;25:123-33.
89. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, et al. Immunologic NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996;274:1917-21.
90. Shi B, Raina J, Lorenzo A, Busciglio J, Gab uzda D. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: Potentiation of neurotoxicity mediated by oxidative stress and implication for HIV-1 dementia. J Neurovirol 1998;4:281-90.
91. Begovac J, Lisic M, Lukas D, Maretic T, Kniewald T, Novotny TE. Marked improvement in survival among adult Croatian AIDS patients after the introduction of highly active antiretroviral treatment. Coll Antropol 2006;30:175-9.
92. Nath A, Geiger J. Neurobiological aspects of human immunodeficiency virus infection: Neurotoxic mechanisms. Progr Neurobiol 1998;54:19-33.
93. Li W, Galey D, Mattson MP, Nath A. Molecular and cellular mechanisms of neuronal cell death in HIV dementia. Neurotox Res 2005;8:119-34.
94. Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurological syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985;313:1493-7.
95. Carne CA, Tedder RS, Smith A, Sutherland S, Elkington SG, Daly HM, et al. Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet 1985;2:1206-8.
96. Denning DW, Anderson J, Rudge P, Smith H. Acute myelopathy associated with primary infection with human immunodeficiency virus. Br Med J 1987;294:143-4.
97. Resnick L, Burger JR, Shapshak P, Tourtellotte WW. Early penetration of the blood-brain-barrier by HIV. Neurology 1988;38:9-14.
98. Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, Merlin TL, et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992;42:1736-9.
99. Gray F, Lescs MC, Keohane C, Paraire F, Marc B, Durigon M, et al. Early brain changes in HIV infection: Neuropathological study of 11 HIV-seropositive, no-AIDS cases. J Neuropathol Exp Neurol 1992;51:177-85.
100. An SF, Giometto B, Scaravilli T, Tavolato B, Gray F, Scaravilli F. Programmed cell death in brains of HIV-1-positive AIDS and pre-AIDS patients. Acta Neuropathol 1996a;91:169-73.
101. An SF, Giometto B, Groves M, Miller RF, Beckett AA, Gray F, et al. Axonal damage revealed by accumulation of β-APP in HIV-positive individuals without AIDS. J Neuropathol Exp Neurol 1997;56:1262-8.
102. An SF, Giometto B, Scaravilli F. HIV-1 DNA in brains in AIDS and pre-AIDS: Correlation with the stage of the disease. Ann Neurol 1996b;40:611-7.
103. An SF, Ciardi A, Giometto B, Scaravilli T, Gray F, Scaravilli F. Investigation on the expression of major histocompatibility complex class II and cytokines and detection of HIV-1 DNA within brains of asymptomatic and symptomatic HIV-1-positive patients. Acta Neuropathol 1996;91:494-503.
104. Wiley CA, Achim C. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 1994;36:673-6.
105. Brew BJ, Rosenblum M, Cronin K, Price RW. AIDS dementia complex and HIV-1 brain infection: Clinical-virological correlations. Ann Neurol 1995;38:563-70.
106. Gray F, Haug H, Chimelli L, Geny C, Gaston A, Scaravilli F, et al. Prominent cortical atrophy with neuronal loss as correlate of human immunodeficiency virus encephalopathy. Acta Neuropathol 1991;82:229-33.
107. Glass JD, Wesselingh SL, Selnes OA, McArthur JC. Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 1993;43:2230-7.
108. Johnson RT, Glass JD, McArthur JC, Chesebro BW. Quantitation of human immunodeficiency virus in brains of demented and non demented patients with acquired immunodeficiency syndrome. Ann Neurol 1996;39:392-5.
109. Lazarini F, Seilhean D, Rosenblum O, Suarez S, Conquy L, Uchihara T, et al. Human immunodeficiency virus type 1 DNA and RNA load in brains of demented and nondemented patients with acquired immunodeficiency syndrome. J Neurovirol 1997;3:299-303.
110. Sinclair E, Gray F, Ciardi A, Scaravilli F. Immunohistochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV-positive patients. J Neuropathol Exp Neurol 1994;53:43-50.
111. Seilhean D, Dzia-Lepfoundzou A, Sazdovitch V, Cannella B, Raine CS, Katlama C, et al. Astrocytic adhesion molecules are increased in HIV-associated cognitive/motor complex. Neuropathol Appl Neurobiol 1997;23:83-92.
112. Geiger KD, Stoldt P, Schlote W, Derouiche A. Ezrin immunoreactivity reveals specific astrocyte activation in cerebral HIV. J Neuropathol Exp Neurol 2006;65:87-96.
113. Vallat AV, De Girolami U, He J, Mhashilkar A, Marasco W, Shi B, et al. Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Pathol 1998;152:167-78.
114. Giometto B, An SF, Groves M, Scaravilli T, Geddes JF, Miller R, et al. Accumulation of beta-amyloid precursor protein in HIV encephalitis: Relationship with neurophysiological abnormalities. Ann Neurol 1997;42:34-40
115. Everall IP, Glass JD, McArthur J, Spargo E, Lantos P. Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia. Acta Neuropathol 1994;88:538-44.
116. Weis S, Haug H, Budka H. Astroglial changes in the cerebral cortex of AIDS brains: A morphometric and immunohistochemical investigation. Neuropathol Appl Neurobiol 1993;19:329-35.
117. Seilhean D, Duyckaerts C, Vazeux R, Bolgert F, Brunet P, Katlama C, et al. HIV-associated cognitive/motor complex: Absence of neuronal loss in the cerebral neocortex. Neurology 1993;43:1492-9.
118. Everall I, Barnes H, Spargo E, Lantos P. Assessment of neuronal density in the putamen in human immunodeficiency virus (HIV) infection. Application of stereology and spatial analysis of quadrats. J Neurovirol 1995;1:126-9.
119. Petito CK, Roberts B, Cantando JD, Rabinstein A, Duncan R. Hippocampal injury and alterations in neuronal chemochine coreceptor expression in patients with AIDS. J Neuropathol Exp Neurol 2001;60:377-85.
120. Gray F, Adle-Biassette H, Chrétien F, et al. Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol 2001;20:146-55.
121. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, et al. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 1997;42:963-72.
122. Everall IP, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, et al. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol 1999;9:209-17.
123. McNaghten AD, Hanson DL, Jones JL. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. AIDS 1999;13:1687-95.
124. Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000;30:S5-14.
125. Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 1997;11:1731-8.
126. Pakker NG, Ross MTL, van Leeuwen R, de Jong MD, Koot M, Reiss P, et al. Patterns of T cell repopulation, virus load reduction and restoration of T cell function in HIV-infected persons during therapy with different antiretrovirals. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:318-26.
127. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, et al. Positive effects of combined antiretroviral therapy on CD4+ T cells homeostasis and function in advanced HIV cases. Science 1997;277:112-6.
128. Jellinger KA, Setinek U, Drilicek M, Bohm G, Steurer A, Lintner F. Neuropathology and general autopsy findings in AIDS during the last 15 years. Acta Neuropathol 2000;100:213-20.
129. Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiat 2000;69:376-80.
130. Sacktor NC, Lyles RH, Skolasky R. The multicenter AIDS Cohort Study. HIV-1-related neurological disease incidence changes in the era of highly active antiretroviral therapy. Neurology 1999;52:A252-3.
131. Jerene D, Naess A, Lindtjorn B. Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients. AIDS Res Ther 2006;3:10.
132. Torre D, Speranza F, Martregani R. Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection. HIV Med 2005;6:66-78.
133. Hoffmann C, Tabrizian S, Wolf E, Eggers C, Stoehr A, Plettenberg A, et al. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 2001;15:2119-27.
134. Boffito M, Pillay D, Wilkins E. Management of advanced HIV disease: Resistance, antiretroviral brain penetration and malignancies. Int J Clin Pract 2006;60:1098-106.
135. Srinivas RV, Midlemas D, Flynn P, Fridland A. Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficiency in cell lines expressing these transporters. Antimicrob Agents Chemother 1998;42:3157-62.
136. Lafeuillade A, Solas C, Halfon P, Chadapaud S, Hittinger G, Lacarelle B. Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: Clinical correlations. HIV Clin Trials 2002;3:27-35.
137. Gray F, Chrétien F, Vallat-Decouvelaere AV, Scaravilli F. The changing pattern of HIV neuropathology in the HAART era. J Neuropathol Exp Neurol 2003;62:429-40.
138. de la Grandmaison GL, Carlier R, Chrétien F, de Truchis P, Orlikowski D, Gray F. Burnt out varicella-zoster-virus encephalitis in an AIDS patient following treatment by highly active antiretroviral therapy. Clin Radiol 2005;60:613-7.
139. Strittmatter C, Lang W, Wiestler OD, Kleihues P. The changing pattern of human immunodeficiency virus- associated cerebral toxoplasmosis: A study of 46 postmortem cases. Acta Neuropathologica 1992;83:475-81.
140. Shelburne SA 3rd, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL, Musher DW, et al. Immune reconstitution inflammatory syndrome: Emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 2002;81:213-27.
141. Crump JA, Tyrer MJ, Lloyd-Owen SJ, Han LY, Lipman MC, Johnson MA. Miliary tuberculosis with paradoxical e xpansion of intracranial tuberculomas complicating immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy. Clin Infect Dis 1998;26:1008-9.
142. Foudraine NA, Hovenkamp E, Notermans DW, Meenhorst PL, Klein MR, Lange JM, et al. Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients. AIDS 1999;13:177-84.
143. Jacobson MA, Zegans M, Pavan PR, O'Donnell JJ, Sattler F, Rao N, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997;349:1143-5.
144. King MD, Perlino CA, Cinnamon J, Jernigan JA. Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: An immune reconstitution syndrome after initiation of highly active antiretroviral therapy. AIDS 2002;13:724-6.
145. Wood ML, MacGinley R, Eisen DP, Allworth AM. HIV combination therapy: Partial immune restitution unmasking latent cryptococcal infection. AIDS 1998;12:1491-4.
146. Miralles P, Berenguer J, Lacruz C, Cosin J, Lopez JC, Padilla B, et al. Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. AIDS 2001;15:1900-2.
147. Tantisiriwat W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ. Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Clin Infect Dis 1998;28:1152-4.
148. Collazos J, Mayo J, Martinez E, Blanco MS. Contrast-enhancing progressive multifocal leukoencephalopathy as an immune reconstitution event in AIDS patients. AIDS 1999;13:426-8.
149. Hoffmann S, Horst HA, Albrecht H, Schlote W. Progressive multifocal leukoencephalopathy with unusual inflammatory response during antiretroviral treatment. J Neurol Neurosurg Psychiat 2003;74:1142-4.
150. Kotecha N, George MJ, Smith TW, Corvi F, Litofsky NS. Enhancing progressive multifocal leukoencephalopathy: An indicator of improved immune status? Am J Med 1998;105:541-3.
151. Langford TD, Letendre SL, Marcotte TD, Ellis RJ, McCutchan JA, Grant I, et al. Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 2002;16:1019-29.
152. Miller RF, Isaacson PG, Hall-Craggs M, Lucas S, Gray F, Scaravilli F, et al. Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART. Acta Neuropathol 2004;108:17-23.
153. Smyth MJ, Kelly JM, Sutton VR, Davis JE, Browne KA, Sayers TJ, et al. Unlocking the secrets of cytoplasmic granule proteins. J Leukoc Biol 2001;70:18-29.
154. Venkatarama A, Pardo CA, McArthur JC, Kerr DA, Irani DN, Griffin JW, et al. Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology 2006;67:383-8.
155. Vendrely A, Bienvenu B, Gasnault J, Thiebault JB, Salmon D, Gray F. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol 2005;109:449-55.
156. Breton G, Seilhean D, Chérin P, Herson S, Benveniste O. Paradoxical intracranial cryptococcoma in a Human Immunodeficiency Virus-infected man being treated with combination Antiretroviral Therapy. Am J Med 2002;113:155-7.
157. Gray F, Bazille C, Adle-Biassette H, Mikol J, Moulignier A, Scaravilli F. Central nervous system immune reconstitution disease in AIDS patients receiving highly active antiretroviral treatment. J Neurovirol 2005;11:16-22.
158. Valcour V, Pail R. HIV infection and dementia in older adults. Clin Infect Dis 2006;42:1449-54.
159. Brew BJ. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 2004;18:S75-8.
160. Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE. Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol 2005;64:529-36.
161. Mercie P, Thiebaut R, Aurillac-Lavignolle V, Pellegrin JL, Yvorra-Vives MC, Cipriano C, et al. Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients. HIV Med 2005;6:380-7.
162. Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL. Brain deposition of beta-amyloid is a common pathologic feature in HIV-positive patients. AIDS 2005;19:407-11.
163. Rempel HC, Pulliam L. HIV-1 tat inhibits neprelysin and elevates amyloid beta. AIDS 2005;19:127-35.
164. Brew BJ, Pemberton L, Blennow K, Wallin A, Hagberg L. CSF amyloid beta 42 and tau levels correlate with AIDS dementia complex. Neurology 2005;65:1490-2.